Nefazodone and cyclosporine drug-drug interaction

Journal of Heart and Lung Transplantation

Volumn 18, Issue 9, 1999, Pages 913-915

  Wright, David H ^a   Lake, Kathleen D ^b   Bruhn, Pamela S ^c   Emery Jr , Robert W ^d,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ABBOTT NORTHWESTERN HOSPITAL   (United States)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^e Cardiac Surgical Associates Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 ISOENZYME; NEFAZODONE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG BLOOD LEVEL; DRUG METABOLISM; FATIGUE; FEMALE; HEADACHE; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ARYL HYDROCARBON HYDROXYLASES; CYCLOSPORINE; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; OXIDOREDUCTASES, N-DEMETHYLATING; TRIAZOLES;

EID: 0032854535     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00036-9     Document Type: Article

References (13)

1. Dew M.A., Roth L.W., Schulberg H.C., et al. Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation. Gen Hosp Psych. 18:(suppl S):1996;S48-S61.
2. Fisher D.C., Lake K.D., Reutzel T.J., Emery R.W. Changes in health-related quality of life and depression in heart transplant recipients. J Heart Lung Transplant. 14:1995;373-381.
3. Serzone® (nefazodone hydrochloride) tablets package insert. Bristol-Myers Squibb. June, 1997.
4. Greene D.S., Dockens R.C., Salazar D.E., Barbhaiya R.H. Coadministration of nefazodone and benzodiazepines. I pharmacokinetic assessment . Clin Pharmacol Ther. 55:1994;141.
5. Barbhaiya R.H., Shukla U.A., Kroboth P.D., Greene D.S. Coadministration of nefazodone and benzodiazepines. II. A pharmacodynamic interaction study with triazolam. J Clin Psychopharmacol. 15:1995;320-326.
6. Watkins P.B. Noninvasive tests of CYP3A enzymes. Pharmacogenetics. 4:1994;171-184.
7. Lake K.D. Management of drug interactions with cyclosporine. Pharmacotherapy. 11:(suppl):1991;110S-118S.
8. Helms-Smith K.M., Curtis S.L. Apparent interaction between nefazodone and cyclosporine. Annals Intern Med. 125:1996;424.
9. Schmider J., Greenblatt D.J., VonMoltke L.L., Harmatz J.S., Shader R.I. Inhibition of cytochrome P450 by nefazodone in vitro studies of dextromethorphan O- and N-demethylation . Br J Clin Pharmacol. 41:1996;339-343.
10. Lampen A., Christians U., Guengerich F.P., et al. Metabolism of the immunosuppressant tacrolimus in the small intestine cytochrome P450, drug interactions, and interindividual variability . Drug Metab Dispos. 23:1995;1315-1324.
11. Cohen L.J. Rational drug use in the treatment of depression. Pharmacotherapy. 17:1997;45-61.
12. Richelson E. Pharmacokinetic drug interactions of new antidepressants a review of the effects on the metabolism of other drugs . Mayo Clin Proc. 72:1997;835-847.
13. VonMoltke L.L., Greenblatt D.J., Schmider J., Harmatz J.S., Shader R.I. Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology. Clin Pharmacokinetics. 29:(suppl 1):1995;33-43.